In a recent post on Facebook, former Minister of Health Aurelijus Veryga launched a sharp critique against Prime Minister Ingrida Ruginienė regarding her acceptance of help from tobacco manufacturers while facing a significant increase in defense expenditures. He highlighted the irony of the government seeking support from these companies, suggesting it undermines public health priorities, particularly in a context where tobacco excise taxes have not been raised adequately. Veryga's comments reflect broader concerns about the ethical implications of financial support from industries that are often viewed as detrimental to health.

The disagreement intensified when Ruginienė accepted drones from Philip Morris International, ostensibly to combat smuggling and hybrid threats at Lithuania’s borders. The Prime Minister framed this gesture by the tobacco company as a responsible action that aligns with national security efforts. She emphasized the importance of corporate responsibility in contributing to national goals, marking it as a promising step. This juxtaposition has prompted discussions about the role of private industries in public health matters and national security.

Veryga's critique signals a potential rift between health and economic policies, as it raises questions about the legitimacy of relying on funds from tobacco companies in a nation where public health is a growing concern. His comments about the Prime Minister's public health degree shedding 'crocodile tears' paint a picture of skepticism towards the government’s commitment to genuine health reforms amidst its economic partnerships. As the debate unfolds, it may influence public opinion and lead to further scrutiny of government decisions regarding health funding and corporate partnerships.